                         SEQUENCE LISTING

<110>  INSERM
       GODEAU, Franois
 
<120>  IGFBP-3 Derivatives and Uses thereof

<130>  BEP090788

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  114
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Gln Arg Ala Arg Pro Thr Leu Trp Ala Ala Ala Leu Thr Leu Leu 
1               5                   10                  15      


Val Leu Leu Arg Gly Pro Pro Val Ala Arg Ala Gly Ala Ser Ser Ala 
            20                  25                  30          


Gly Leu Gly Pro Val Val Arg Cys Glu Pro Cys Asp Ala Arg Ala Leu 
        35                  40                  45              


Ala Gln Cys Ala Pro Pro Pro Ala Val Cys Ala Glu Leu Val Arg Glu 
    50                  55                  60                  


Pro Gly Cys Gly Cys Cys Leu Thr Cys Ala Leu Ser Glu Gly Gln Pro 
65                  70                  75                  80  


Cys Gly Ile Tyr Thr Glu Arg Cys Gly Ser Gly Leu Arg Cys Gln Pro 
                85                  90                  95      


Ser Pro Asp Glu Ala Arg Pro Leu Gln Ala Leu Leu Asp Gly Arg Gly 
            100                 105                 110         


Leu Cys 
        


<210>  2
<211>  98
<212>  PRT
<213>  Homo sapiens

<400>  2

Val Asn Ala Ser Ala Val Ser Arg Leu Arg Ala Tyr Leu Leu Pro Ala 
1               5                   10                  15      


Pro Pro Ala Pro Gly Asn Ala Ser Glu Ser Glu Glu Asp Arg Ser Ala 
            20                  25                  30          


Gly Ser Val Glu Ser Pro Ser Val Ser Ser Thr His Arg Val Ser Asp 
        35                  40                  45              


Pro Lys Phe His Pro Leu His Ser Lys Ile Ile Ile Ile Lys Lys Gly 
    50                  55                  60                  


His Ala Lys Asp Ser Gln Arg Tyr Lys Val Asp Tyr Glu Ser Gln Ser 
65                  70                  75                  80  


Thr Asp Thr Gln Asn Phe Ser Ser Glu Ser Lys Arg Glu Thr Glu Tyr 
                85                  90                  95      


Gly Pro 
        


<210>  3
<211>  79
<212>  PRT
<213>  Homo sapiens

<400>  3

Cys Arg Arg Glu Met Glu Asp Thr Leu Asn His Leu Lys Phe Leu Asn 
1               5                   10                  15      


Val Leu Ser Pro Arg Gly Val His Ile Pro Asn Cys Asp Lys Lys Gly 
            20                  25                  30          


Phe Tyr Lys Lys Lys Gln Cys Arg Pro Ser Lys Gly Arg Lys Arg Gly 
        35                  40                  45              


Phe Cys Trp Cys Val Asp Lys Tyr Gly Gln Pro Leu Pro Gly Tyr Thr 
    50                  55                  60                  


Thr Lys Gly Lys Glu Asp Val His Cys Tyr Ser Met Gln Ser Lys 
65                  70                  75                  


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker

<400>  4

Gly Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly 
1               5                   10                  15  


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ALS non binding site

<400>  5

Ala Gly Gly Ser Gly 
1               5   


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  BirA enzyme substrate

<400>  6

Gly Leu Asn Asp Ile Phe Glu Ala Gln Lys Ile Glu Trp His Glu 
1               5                   10                  15  


<210>  7
<211>  44
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  7
atcgaaggcc gtgggggcca gggcgcgagc tcggggggct tggg                        44


<210>  8
<211>  52
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  8
cctcgagtta tcagctgccc ttgctctgca tgctgtagca gtgcacgtcc tc               52


<210>  9
<211>  84
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mutagenic oligonucleotide

<400>  9
gggaccatat tctgtctcac caccagaccc gccagacccg ccagacccgc cagacccgcc       60

accgctgacg gcactagcgt tgac                                              84


<210>  10
<211>  50
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mutagenic oligonucleotide

<400>  10
ccacacacca gcagaagccg ccgctgccgc ccgcggaagg gcgacactgc                  50


<210>  11
<211>  76
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mutagenic oligonucleotide

<400>  11
cccctcgagt cattattcgt gccattcaat tttttgggct tcaaaaatgt cgttcaggcc       60

gctgcccttg ctctgc                                                       76


